Bookshelf

Bookshelf provides free online access to books and documents in life science and healthcare. Search, read, and discover.

Using Bookshelf

Read

Participate

New & Updated

Clinical Review Report: abobotulinumtoxinA (Dysport Therapeutic): (Ipsen Biopharmaceuticals Canada Inc.): Indication: For the symptomatic treatment of lower-limb spasticity in pediatric patients 2 years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Clinical Review Report: Tapentadol Hydrochloride Extended-Release Tablet (Nucynta Extended-Release): (Paladin Labs Inc.): Indication: Management of pain severe enough to require daily, continuous, long-term opioid treatment, and: that is opioid responsive; and for which alternative treatment options are inadequate. Tapentadol extended-release tablet is not indicated as an as-needed (prn) analgesic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.
Pharmacoeconomic Review Report: abobotulinumtoxinA (Dysport Therapeutic): (Ipsen Biopharmaceuticals Canada, Inc.): Indication: For the symptomatic treatment of lower-limb spasticity in pediatric patients 2 years of age and older [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Pharmacoeconomic Review Report: Riociguat (Adempas) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Dec.
Pharmacoeconomic Review Report: Tapentadol Hydrochloride Extended-Release Tablet (Nucynta Extended-Release): (Paladin Labs Inc.): Indication: Management of pain severe enough to require daily, continuous, long-term opioid treatment, and: that is opioid responsive; and for which alternative treatment options are inadequate. Tapentadol extended-release tablet is not indicated as an as-needed (prn) analgesic [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.

Featured Titles

Behavioral Counseling for Skin Cancer Prevention: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Evidence Synthesis, No. 161.
Henrikson NB, Morrison CC, Blasi PR, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar.
Biodefense in the Age of Synthetic Biology.
National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Life Sciences; Board on Chemical Sciences and Technology; Committee on Strategies for Identifying and Addressing Potential Biodefense Vulnerabilities Posed by Synthetic Biology.
Washington (DC): National Academies Press (US); 2018 Jun 19.
Internet-based Brief Interventions for Substance Misuse in Youth and Young Adults: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines [Internet].
Tran K, Spry C.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jun 7.
Learning Through Citizen Science: Enhancing Opportunities by Design.
National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Board on Science Education; Committee on Designing Citizen Science to Support Science Learning; Dibner KA, Pandya R, editors.
Washington (DC): National Academies Press (US); 2018 Nov 1.
Treatment for Bipolar Disorder in Adults: A Systematic Review [Internet].
Comparative Effectiveness Review, No. 208.
Butler M, Urosevic S, Desai P, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug.